Ensuring access to safe, effective, and affordable cannabis-based medicines

Br J Clin Pharmacol. 2020 Apr;86(4):630-634. doi: 10.1111/bcp.14242. Epub 2020 Mar 3.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cannabis*
  • Hallucinogens*
  • Health Services Accessibility
  • Humans
  • Medical Marijuana* / adverse effects

Substances

  • Hallucinogens
  • Medical Marijuana